pandemic
August 12, 2021
Pandemic Impact

CBD Global Sciences Debt Restructuring and Impact of both Global NV and Strasburg Pharms Bankruptcies, Post Bankruptcy Action Plans

CBD Global Sciences, Inc. is pleased to share detailed information about the debt restructuring of the company and the outcome of the two Chapter 7 bankruptcies. The landscape for CBD Global Sciences has changed dramatically since the emergence from the global pandemic and the completion of the two bankruptcies for […]
Do you like it?0
Read more
July 27, 2021
Alberta Securities Commission

CBD Global Sciences Management Cease Trade Order (MCTO) Revoked by the Alberta Securities Commission

CBD Global Sciences, Inc. acknowledges the Cease Trade Order (CTO) issued by the Alberta Securities Commission on 7/23/21. This past Friday the Alberta Securities Commission revoked a MCTO and issued a CTO to the company ceasing all trading of the security until financials are filed for the year end 2020. […]
Do you like it?0
Read more
May 28, 2021
Second Bi-Weekly Status Report

CBD Global Issues Second Bi-Weekly Status Report Regarding Management Cease Trade Order

CBD Global Sciences Inc. further to its press release dated May 14, 2021 provides this second bi-weekly default status report in accordance with National Policy 12-203 – Cease Trade Orders for Continuous Disclosure Defaults (“NP 12-203”). In the Corporation’s initial default announcement of April 14, 2021 (the “Default Notice”), the Corporation announced […]
Do you like it?0
Read more
May 14, 2021
First Bi-Weekly Report

CBD Global Issues First Bi-Weekly Report Regarding Management Cease Trade Order

 CBD Global Sciences Inc. provides this initial bi-weekly default status report in accordance with National Policy 12-203 – Cease Trade Orders for Continuous Disclosure Defaults (“NP 12-203”). In the Corporation’s initial default announcement of April 14, 2021 (the “Default Notice”), the Corporation announced the delay in the filing of its audited annual […]
Do you like it?0
Read more
April 14, 2021
Delayed Filing of Annual Financial Statements

CBD Global Announces Delayed Filing of Annual Financial Statements and MD&A and Application for Management Cease Trade Order

CBD Global Sciences Inc. would like to provide an update on the status of the filing of its annual financial statements, accompanying management’s discussion and analysis and related CEO and CFO certifications for the year ended December 31, 2020 (collectively, the “Annual Filings“). Due to the continued impact of COVID-19, […]
Do you like it?0
Read more